A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s244176
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

A Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Increased Serum Levels of Interleukin-10 Predict Poor Prognosis in Extranodal Natural Killer/T-Cell Lymphoma Patients Receiving Asparaginase-Based Chemotherapy

OncoTargets and Therapy
OncologyPharmacology
2015English

Treatment Benefit Associating With Non-Anthracycline Chemotherapy in Extranodal Nk/T-Cell Lymphoma, Nasal Type

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Maxillary Sinus Natural Killer/T-Cell Extranodal Lymphoma Mimicking a Dentoalveolar Abscess

Case Reports in Dentistry
Dentistry
2019English

Clinical Characteristics and Treatment of 69 Patients With Extranodal Natural Killer T-Cell Lymphoma

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

CD30+ Extranodal Natural Killer/T‑cell Lymphoma Mimicking Phlegmonous Myositis: A Case Report

Oncology Letters
Cancer ResearchOncology
2014English

Extranodal Natural Killer/T-Cell Lymphoma: Current Concepts in Biology and Treatment

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2009English

Chemotherapy Combined With High-Dose Extended-Field Radiotherapy for Stage I Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Involving Skin Masquerading as Eczema

Annals of Dermatology
Dermatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy